Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
Avadel Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | 90.66% |
| March 31, 2025 | 89.38% |
| December 31, 2024 | 90.45% |
| September 30, 2024 | 87.70% |
| June 30, 2024 | 93.28% |
| March 31, 2024 | 94.40% |
| December 31, 2023 | 96.44% |
| September 30, 2023 | 89.85% |
| June 30, 2023 | 57.42% |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 65.43% |
| March 31, 2020 | 78.27% |
| December 31, 2019 | 76.17% |
| September 30, 2019 | 78.72% |
| June 30, 2019 | 78.20% |
| Date | Value |
|---|---|
| March 31, 2019 | 78.91% |
| December 31, 2018 | 71.73% |
| September 30, 2018 | 76.09% |
| June 30, 2018 | 82.48% |
| March 31, 2018 | 74.89% |
| December 31, 2017 | 82.44% |
| September 30, 2017 | 89.03% |
| June 30, 2017 | 88.93% |
| March 31, 2017 | 91.49% |
| December 31, 2016 | 87.09% |
| September 30, 2016 | 91.14% |
| June 30, 2016 | 80.42% |
| March 31, 2016 | 79.51% |
| December 31, 2015 | 87.11% |
| September 30, 2015 | 88.95% |
| June 30, 2015 | 88.16% |
| March 31, 2015 | 79.30% |
| December 31, 2014 | -46.09% |
| September 30, 2014 | 30.99% |
| June 30, 2014 | 43.41% |
| March 31, 2014 | 18.96% |
| December 31, 2013 | 94.83% |
| September 30, 2013 | 68.91% |
| June 30, 2013 | 76.85% |
| March 31, 2013 | 80.64% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 76.30% |
| Perrigo Co. Plc | 30.73% |
| GH Research Plc | -- |
| Cosmo NV | -- |
| Alkermes Plc | 75.30% |